1702 related articles for article (PubMed ID: 18713542)
41. Acute renal failure after liver transplantation: incidence, etiology, therapy, and outcome.
Junge G; Schewior LV; Kohler S; Neuhaus R; Langrehr JM; Tullius S; Kahl A; Frei U; Neuhaus P
Transplant Proc; 2006 Apr; 38(3):723-4. PubMed ID: 16647455
[TBL] [Abstract][Full Text] [Related]
42. N-acetylcysteine for the prevention of kidney injury in abdominal aortic surgery: a randomized, double-blind, placebo-controlled trial.
Hynninen MS; Niemi TT; Pöyhiä R; Raininko EI; Salmenperä MT; Lepäntalo MJ; Railo MJ; Tallgren MK
Anesth Analg; 2006 Jun; 102(6):1638-45. PubMed ID: 16717300
[TBL] [Abstract][Full Text] [Related]
43. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of serum cystatin C for diagnosis of acute rejection after renal transplantation.
Liu J
Transplant Proc; 2012 Jun; 44(5):1250-3. PubMed ID: 22663994
[TBL] [Abstract][Full Text] [Related]
45. Risk factors for acute renal failure requiring dialysis after liver transplantation.
Bilbao I; Charco R; Balsells J; Lazaro JL; Hidalgo E; Llopart L; Murio E; Margarit C
Clin Transplant; 1998 Apr; 12(2):123-9. PubMed ID: 9575400
[TBL] [Abstract][Full Text] [Related]
46. RIFLE criteria and hepatic function in the assessment of acute renal failure in liver transplantation.
Tinti F; Umbro I; Meçule A; Rossi M; Merli M; Nofroni I; Corradini SG; Poli L; Pugliese F; Ruberto F; Berloco PB; Mitterhofer AP
Transplant Proc; 2010 May; 42(4):1233-6. PubMed ID: 20534269
[TBL] [Abstract][Full Text] [Related]
47. Acute renal failure after cadaveric related liver transplantation.
Chuang FR; Lin CC; Wang PH; Cheng YF; Hsu KT; Chen YS; Lee CH; Chen CL
Transplant Proc; 2004 Oct; 36(8):2328-30. PubMed ID: 15561239
[TBL] [Abstract][Full Text] [Related]
48. Estimation of benchmark dose as the threshold levels of urinary cadmium, based on excretion of total protein, beta2-microglobulin, and N-acetyl-beta-D-glucosaminidase in cadmium nonpolluted regions in Japan.
Kobayashi E; Suwazono Y; Uetani M; Inaba T; Oishi M; Kido T; Nishijo M; Nakagawa H; Nogawa K
Environ Res; 2006 Jul; 101(3):401-6. PubMed ID: 16436274
[TBL] [Abstract][Full Text] [Related]
49. [Clinical significance of urinary N-acetyl-beta-D-glucosaminidase activities in surgery].
Kamioka T
Nihon Geka Gakkai Zasshi; 1985 Jun; 86(6):657-68. PubMed ID: 4033621
[TBL] [Abstract][Full Text] [Related]
50. Role of N-terminal pro-brain natriuretic peptide and cystatin C to estimate renal function in patients with and without heart failure.
Linzbach S; Samigullin A; Yilmaz S; Tsioga M; Zeiher AM; Spyridopoulos I
Am J Cardiol; 2009 Apr; 103(8):1128-33. PubMed ID: 19361601
[TBL] [Abstract][Full Text] [Related]
51. [Value of blood apoH gene expression and urinary NAG and RBP in early diagnosis of renal function damage in neonates].
Wu ZJ; Huang SM; Chen R; Hu B; Chen Y; Zhu YP; Lu GJ; Han YK
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Aug; 11(8):649-52. PubMed ID: 19695192
[TBL] [Abstract][Full Text] [Related]
52. Serum cystatin C level for better assessment of glomerular filtration rate in cystic fibrosis patients treated by amikacin.
Halacova M; Kotaska K; Kukacka J; Vavrova V; Kuzelova M; Ticha J; Prusa R
J Clin Pharm Ther; 2008 Aug; 33(4):409-17. PubMed ID: 18613859
[TBL] [Abstract][Full Text] [Related]
53. Serum cystatin C in elderly cardiac surgery patients.
Ristikankare A; Pöyhiä R; Kuitunen A; Skrifvars M; Hämmäinen P; Salmenperä M; Suojaranta-Ylinen R
Ann Thorac Surg; 2010 Mar; 89(3):689-94. PubMed ID: 20172110
[TBL] [Abstract][Full Text] [Related]
54. The inaccuracy of cystatin C and creatinine-based equations in predicting GFR in orthotopic liver transplant recipients.
Boudville N; Salama M; Jeffrey GP; Ferrari P
Nephrol Dial Transplant; 2009 Sep; 24(9):2926-30. PubMed ID: 19506046
[TBL] [Abstract][Full Text] [Related]
55. Fetal serum α-1 microglobulin for renal function assessment: comparison with β2-microglobulin and cystatin C.
Nguyen C; Dreux S; Heidet L; Czerkiewicz I; Salomon LJ; Guimiot F; Schmitz T; Tsatsaris V; Boulot P; Rousseau T; Muller F
Prenat Diagn; 2013 Aug; 33(8):775-81. PubMed ID: 23592560
[TBL] [Abstract][Full Text] [Related]
56. [Acute renal failure in patients undergoing cardiac surgery].
Sladoje-Martinović B; Orlić L; Zupan Z; Matić-Glazar D; Prodan-Merlak Z
Acta Med Croatica; 2004; 58(5):417-20. PubMed ID: 15756810
[TBL] [Abstract][Full Text] [Related]
57. Early renal injury after nonmyeloablative allogeneic peripheral blood stem cell transplantation in patients with chronic myelocytic leukemia.
Liu H; Ding JH; Liu BC; Zhao G; Chen BA
Am J Nephrol; 2007; 27(4):336-41. PubMed ID: 17519537
[TBL] [Abstract][Full Text] [Related]
58. In fetuses with isolated hydronephrosis, urinary beta 2-microglobulin and N-acetyl-beta-D-glucosaminidase (NAG) have a limited role in the prediction of postnatal renal function.
Tassis BM; Trespidi L; Tirelli AS; Bocconi L; Zoppini C; Nicolini U
Prenat Diagn; 1996 Dec; 16(12):1087-93. PubMed ID: 8994243
[TBL] [Abstract][Full Text] [Related]
59. N-acetyl-beta-D-glucosaminidase is not a predictor, but an indicator of kidney injury in patients with cardiac surgery.
Hamada Y; Kanda T; Anzai T; Kobayashi I; Morishita Y
J Med; 1999; 30(5-6):329-36. PubMed ID: 10851566
[TBL] [Abstract][Full Text] [Related]
60. Cystatin C as a marker of renal function immediately after liver transplantation.
Biancofiore G; Pucci L; Cerutti E; Penno G; Pardini E; Esposito M; Bindi L; Pelati E; Romanelli A; Triscornia S; Salvadorini MP; Stratta C; Lanfranco G; Pellegrini G; Del Prato S; Salizzoni M; Mosca F; Filipponi F
Liver Transpl; 2006 Feb; 12(2):285-91. PubMed ID: 16447198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
